A Study Evaluating the Application of Hearing Aid Technologies to Signal Processing for Adult Cochlear Implant Recipients
NCT ID: NCT05866770
Last Updated: 2025-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
150 participants
INTERVENTIONAL
2023-09-11
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Investigation to Evaluate Sound Coding Enhancements in Adult Cochlear Implant Recipients
NCT06867380
Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients
NCT05619575
New Algorithms to Signal Processing for Speech Enhancement in Adult Cochlear Implant Recipients.
NCT06100393
Subject´s Preference Regarding Hearing Performance and Functionality Using a New Sound Processor
NCT03848910
Outcome Prediction in Cochlear Implant Recipients
NCT02984748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
U8 then N8
Participants in this arm receive U8 followed by N8
U8
The U8 Research System
N8 sound processor
Nucleus 8 sound processor
N8 then U8
Participants in this arm receive N8 followed by U8
U8
The U8 Research System
N8 sound processor
Nucleus 8 sound processor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
U8
The U8 Research System
N8 sound processor
Nucleus 8 sound processor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* User of CI600, CI500 or CI24RE implant
* At least 3 months experience with a TGA approved Nucleus cochlear implant in at least one ear
* Fluent speaker of English
* A word speech recognition score of 20% or more when using the cochlear implant alone\*
* Willing and able to provide written informed consent \*This can be based on clinical data if collected within the last 12 months
Exclusion Criteria
* Investigator site personnel directly affiliated with this study and/or their immediate families: immediate family is defined as a spouse, parent, child, or sibling
* Cochlear employees or employees of Contract Research Organizations or contractors engaged by Cochlear for the purposes of this investigation.
* Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device. (Unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Avania
INDUSTRY
Cochlear
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cochlear Melbourne
Melbourne E., melbourne, Australia
Cochlear Macquarie
Sydney, New South Wales, Australia
HEARnet Clinical Studies
Carlton, Victoria, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AI5837
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.